I’ll look anyone straight in the eye and say, ‘This is certainly good for the insurer, very good for the patient, and economically good for the doctor. Why can’t we set something up where everyone does well, as opposed to everyone doing badly?

–Roy Beveridge, MD, Medical Director for US Oncology, describing his company’s new program, Innovent Oncology.

US Oncology, the nation’s largest chain of cancer clinics, and Cancer Clinics of Excellence, a group of independent clinics, both see clinical pathways as a key component of payment reform for oncologists. To learn more, read my article in Oncology Times.